Clinical Trials Browser

Phase 2 × Interventional × Arsenic × Clear all

NCT06982274 2025-05-30

IC-APL2020

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT04695223 2021-01-06

Arsenic Trioxide for Structural p53 Mutations

Phase 2 Unknown

Neoplasms

NCT03381781 2018-01-04

Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute